These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27841182)

  • 1. Molecular screening of intellectually disabled patients and those with premature ovarian failure for CGG repeat expansion at FMR1 locus: Implication of combined triplet repeat primed polymerase chain reaction and methylation-specific polymerase chain reaction analysis.
    Muthuswamy S; Dean DD; Agarwal S
    Neurol India; 2016; 64(6):1175-1179. PubMed ID: 27841182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat expansion and methylation-sensitive triplet-primed polymerase chain reaction for fragile X mental retardation 1 gene screening in institutionalised intellectually disabled individuals.
    Sihombing NRB; Cai S; Wong DPW; Guan M; Chong SS; Faradz SMH; Winarni TI
    Singapore Med J; 2021 Mar; 62(3):143-148. PubMed ID: 31989181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Triplet expansion cytosine-guanine-guanine: Three cases of OMIM syndrome in the same family].
    González-Pérez J; Izquierdo-Álvarez S; Fuertes-Rodrigo C; Monge-Galindo L; Peña-Segura JL; López-Pisón FJ
    Med Clin (Barc); 2016 Apr; 146(7):311-5. PubMed ID: 26776484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of FMR1 triplet repeats in patients affected with mental retardation, fragile X syndrome and primary ovarian insufficiency.
    Salimy Z; Akbari MT; Deilamani FK
    J Genet; 2020; 99():. PubMed ID: 32089525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Genetic Testing for Fragile X Syndrome by Polymerase Chain Reaction Amplification and Southern Blot Analyses.
    Cai X; Arif M; Wan H; Kornreich R; Edelmann LJ
    Methods Mol Biol; 2019; 1942():11-27. PubMed ID: 30900172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative assessment of FMR1 (CGG)n triplet repeat status in normal, intermediate, premutation, full mutation, and mosaic carriers in both sexes: implications for fragile X syndrome carrier and newborn screening.
    Hantash FM; Goos DG; Tsao D; Quan F; Buller-Burckle A; Peng M; Jarvis M; Sun W; Strom CM
    Genet Med; 2010 Mar; 12(3):162-73. PubMed ID: 20168238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular diagnosis of fragile X syndrome using methylation sensitive techniques in a cohort of patients with intellectual disability.
    Chaudhary AG; Hussein IR; Abuzenadah A; Gari M; Bassiouni R; Sogaty S; Lary S; Al-Quaiti M; Al Balwi M; Al Qahtani M
    Pediatr Neurol; 2014 Apr; 50(4):368-76. PubMed ID: 24630283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the human fragile X mental retardation 1 polymerase chain reaction reagents to amplify the FMR1 gene: testing in a clinical diagnostic laboratory.
    Nahhas FA; Monroe TJ; Prior TW; Botma PI; Fang J; Snyder PJ; Talbott SL; Feldman GL
    Genet Test Mol Biomarkers; 2012 Mar; 16(3):187-92. PubMed ID: 21992462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triplet-Primed PCR Assays for Accurate Screening of FMR1 CGG Repeat Expansion and Genotype Verification.
    Rajan-Babu IS; Lian M; Chong SS
    Curr Protoc; 2022 May; 2(5):e427. PubMed ID: 35609145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of patterns of inheritance of premature ovarian failure syndrome carrying maternal and paternal premutations.
    Beke A; Piko H; Haltrich I; Karcagi V; Rigo J; Molnar MJ; Fekete G
    BMC Med Genet; 2018 Jul; 19(1):113. PubMed ID: 29986653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene.
    Wang H; Zhu X; Gui B; Cheung WC; Shi M; Yang Z; Kwok KY; Lim R; Pietilä S; Zhu Y; Choy KW
    J Vis Exp; 2019 Sep; (151):. PubMed ID: 31566610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragile X syndrome screening in pregnant women and women planning pregnancy shows a remarkably high FMR1 premutation prevalence in the Balearic Islands.
    Alfaro Arenas R; Rosell Andreo J; Heine Suñer D;
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1023-1031. PubMed ID: 27333191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Characterization of FMR1 Gene by TP-PCR in Women of Reproductive Age and Women with Premature Ovarian Insufficiency.
    Dean DD; Agarwal S; Kapoor D; Singh K; Vati C
    Mol Diagn Ther; 2018 Feb; 22(1):91-100. PubMed ID: 29188551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplified strategy for rapid first-line screening of fragile X syndrome: closed-tube triplet-primed PCR and amplicon melt peak analysis.
    Rajan-Babu IS; Law HY; Yoon CS; Lee CG; Chong SS
    Expert Rev Mol Med; 2015 May; 17():e7. PubMed ID: 25936533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragile X CGG repeat variation in Tamil Nadu, South India: a comparison of radioactive and methylation-specific polymerase chain reaction in CGG repeat sizing.
    Indhumathi N; Singh D; Chong SS; Thelma BK; Arabandi R; Srisailpathy CR
    Genet Test Mol Biomarkers; 2012 Feb; 16(2):113-22. PubMed ID: 22023245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of screening strategies for fragile X syndrome in the UK.
    Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G
    Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of molecular approach in screening for fragile X premutation cases.
    Refeat MM; El Saied MM; Abdel Raouf ER
    Ir J Med Sci; 2023 Oct; 192(5):2265-2272. PubMed ID: 36409419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FMR1 CGG repeat expansion mutation detection and linked haplotype analysis for reliable and accurate preimplantation genetic diagnosis of fragile X syndrome.
    Rajan-Babu IS; Lian M; Cheah FSH; Chen M; Tan ASC; Prasath EB; Loh SF; Chong SS
    Expert Rev Mol Med; 2017 Jul; 19():e10. PubMed ID: 28720156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of fragile X syndrome.
    Basehore MJ; Friez MJ
    Curr Protoc Hum Genet; 2014 Jan; 80():9.5.1-9.5.19. PubMed ID: 24510684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triplet-Repeat Primed PCR and Capillary Electrophoresis for Characterizing the Fragile X Mental Retardation 1 CGG Repeat Hyperexpansions.
    Rajan-Babu IS; Chong SS
    Methods Mol Biol; 2019; 1972():199-210. PubMed ID: 30847793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.